We make all data, including variant age estimation and pairwise ancestry results, as well as the movies generated from our results, publicly available online: <https://human.genome.dating>

Introduction {#sec001}
============

Each generation, a human genome acquires an average of about 70 single-nucleotide changes through mutation in the germline of its parents \[[@pbio.3000586.ref001]\]. Yet while, at a global scale, many millions of new variants are generated each year, the vast majority are lost rapidly through genetic drift and purifying selection. Consequently, even though the majority of variants themselves are extremely rare, the majority of genetic differences between genomes result from variants found at global frequencies of 1% or more \[[@pbio.3000586.ref002]\], which may have appeared thousands of generations ago. Genome sequencing studies \[[@pbio.3000586.ref003]\] have catalogued the vast majority of common variation (estimated to be about 10 million variants \[[@pbio.3000586.ref004]\]), and, at least within coding regions and particular ancestries, to date, more than 660 million variants genome-wide have been reported \[[@pbio.3000586.ref005]\], many of them at extremely low frequency \[[@pbio.3000586.ref002]\].

Despite the importance of genetic variation in influencing quantitative traits and risk for disease, as well as providing the raw material on which natural selection can act, relatively little attention has been paid to inferring the evolutionary history of the variants themselves, with notable exceptions of evolutionary importance, particularly those affecting geographically varying traits such as skin pigmentation, diet, and immunity \[[@pbio.3000586.ref006]--[@pbio.3000586.ref008]\]. Rather, attention has focused on the indirect use of genetic variation to detect population structure \[[@pbio.3000586.ref009], [@pbio.3000586.ref010]\], identify related samples \[[@pbio.3000586.ref011], [@pbio.3000586.ref012]\], infer parameters of models of human demographic history \[[@pbio.3000586.ref013], [@pbio.3000586.ref014]\], and estimate the time of ancestral population divergence \[[@pbio.3000586.ref015]\]. The evolutionary history of classes of variants contributing to polygenic adaptation (for example, those affecting height \[[@pbio.3000586.ref006], [@pbio.3000586.ref016], [@pbio.3000586.ref017]\]) or causing potential loss of gene function \[[@pbio.3000586.ref018]\] has received attention, though rarely at the level of specific variants. Previous work on rare variants has identified ancestral connections between individuals and populations \[[@pbio.3000586.ref019]--[@pbio.3000586.ref021]\] and demonstrated evidence for explosive population growth \[[@pbio.3000586.ref022]\]. Nevertheless, to date, no comprehensive effort has been made to infer the age, place of origin, or pattern of spread for the vast majority of variants.

We have developed a method for estimating the age of genetic variants; that is, the time of origin of an allele through mutation at a single locus. Our approach, which we refer to as the Genealogical Estimation of Variant Age (GEVA), is similar to existing methods that involve coalescent modeling to infer the time to the most recent common ancestor (TMRCA) between individual genomes \[[@pbio.3000586.ref013], [@pbio.3000586.ref023], [@pbio.3000586.ref024]\]. However, these methods typically operate on a discretized timescale \[[@pbio.3000586.ref013]\], utilize only a fraction of the information available in larger sample data \[[@pbio.3000586.ref025]\], or employ approximations to overcome computational complexity \[[@pbio.3000586.ref014], [@pbio.3000586.ref015], [@pbio.3000586.ref026]\]. Alternate approaches, in particular those that have been used to indicate allele age, are often strongly parameterized and make assumptions about demographic history, selection, or the shape of genealogical trees \[[@pbio.3000586.ref027]--[@pbio.3000586.ref030]\]. Recently proposed approaches for genealogical inference are also able to estimate allele age by placing mutation events on the branches of reconstructed trees at variable sites \[[@pbio.3000586.ref031], [@pbio.3000586.ref032]\]. Our work is motivated by the desire for a fast and scalable nonparametric estimator of allele age that makes no assumptions about the demographic or selective processes that shaped the underlying genealogy and that is robust to the frequency and types of error found in modern whole-genome population sequencing studies. We learn about the age of a mutation by combining probabilistic distributions of the TMRCA between hundreds or thousands of genomes on a continuous timescale, irrespective of contemporary allelic distributions or historic population boundaries and without the need to fully reconstruct genealogies.

The approach used within GEVA is outlined in [Fig 1](#pbio.3000586.g001){ref-type="fig"}. A copy of the piece of the ancestral chromosome on which the mutation occurred is still present today in the individuals carrying the derived allele ([Fig 1A](#pbio.3000586.g001){ref-type="fig"}). Over time, additional mutations have accumulated along the inherited sequence (haplotype), and its length has been broken down by recombination during meiosis in each generation. We locate this ancestral segment (often referred to as an identity-by-descent \[IBD\] region) relative to the position of a given target variant using a hidden Markov model (HMM) constructed empirically from sequencing data to provide robustness to realistic rates of sequencing and genotyping error ([Fig 1B](#pbio.3000586.g001){ref-type="fig"}). By measuring the impact of mutation and recombination on the segments shared between pairs of haplotypes, we infer the TMRCA using probabilistic models to accommodate the stochastic nature of mutation and recombination processes ([Fig 1C](#pbio.3000586.g001){ref-type="fig"}). Moreover, we make full use of the information available in whole-genome sequencing data to perform comparisons between pairs of chromosomes that both carry the mutation (concordant pairs) and pairs in which one carries the mutation and the other carries the ancestral allele (discordant pairs), thereby considering genealogical relationships that are both younger and older, respectively, than the time of mutation. Information from hundreds or thousands of haplotype pairs is then combined within a composite-likelihood framework to obtain an approximate posterior distribution on the age of the derived allele ([Fig 1D](#pbio.3000586.g001){ref-type="fig"}). One benefit of our method is that we can increase the number of pairwise TMRCA inferences incrementally to update age estimates or to combine information across many data sources to improve the genealogical resolution from a wider distribution of independently sampled genomes. We additionally use a heuristic method for rejecting outlier pairs to improve robustness to low rates of data error and recurrent mutation. Full details are given in [S1 Text](#pbio.3000586.s014){ref-type="supplementary-material"}.

![Overview of the GEVA method.\
(A) At the chromosomal location of a variant, there exists an underlying (and unknown) genealogical tree describing the relationship between the samples. We assume that the derived allele (inferred by comparison to outgroup sequences) arose once in the tree. For concordant pairs of carrier chromosomes (yellow terminal nodes), their MRCAs (blue nodes) occur more recently than the focal mutation event. For discordant pairs of chromosomes, between the ancestral allele (green terminal nodes) and the derived allele, the MRCAs (red nodes) are older than the focal mutation. (B) For each pair of chromosomes (concordant and discordant), we use a simple HMM with an empirically calibrated error model to estimate the region over which the MRCA does not change; that is, the distance to the first detectable recombination event either side of the focal position along the sequence. From the inferred ancestral segment, we obtain the genetic distance and the number of mutations that have occurred on the branches leading from the MRCA to the sample chromosomes. (C) For each pair of chromosomes, we use probabilistic models (see [S1 Text](#pbio.3000586.s014){ref-type="supplementary-material"}) to estimate the posterior distribution of the TMRCA, represented as cumulative distributions of having coalesced for concordant pairs (blue) and of having not coalesced for discordant pairs (red). (D) An estimate of the composite posterior distribution for the time of origin of the mutation is obtained by combining the cumulative distributions for concordant and discordant pairs. Informally, the mutation is expected to be older than concordant and younger than discordant pairs. In practice, this composite-likelihood--based approach results in approximate posteriors that are overconfident; hence, they are summarized by the mode of the distribution. Additional filtering steps are carried out to remove inconsistent pairs of samples (see [S1 Text](#pbio.3000586.s014){ref-type="supplementary-material"}). GEVA, Genealogical Estimation of Variant Age; HMM, hidden Markov model; MRCA, most recent common ancestor; TMRCA, time to the most recent common ancestor.](pbio.3000586.g001){#pbio.3000586.g001}

Results {#sec002}
=======

Simulation study {#sec003}
----------------

To validate GEVA, we performed coalescent simulations under different demographic models; see [Fig 2](#pbio.3000586.g002){ref-type="fig"}. Using a standard coalescent model with constant mutation and recombination rates, we found low bias (relative error, *ε* = 0.268; see [S2 Text](#pbio.3000586.s015){ref-type="supplementary-material"}) for allele age estimates and high correlation between true and inferred age (Spearman\'s *ρ* = 0.953; [Fig 2A](#pbio.3000586.g002){ref-type="fig"}). We compared our approach for estimating the TMRCA to the computationally more demanding pairwise sequentially Markovian coalescent (PSMC) methodology \[[@pbio.3000586.ref013]\], which forms the basis of many applications in ancestral inference \[[@pbio.3000586.ref014], [@pbio.3000586.ref026]\]. PSMC estimates a model of the demographic history between pairs of chromosomes (over a discretized grid of time intervals) and can, for every position in the genome, return the inferred posterior distribution on the TMRCA, thus enabling a composite-likelihood estimator of allele age as in GEVA.

![Validation of GEVA through coalescent simulations.\
(A) Density scatterplots showing the relationship between true allele age (geometric mean of lower and upper age of the branch on which a mutation occurred; *x* axis) and estimated allele age (*y* axis), using GEVA with the in-built HMM methodology (left) and PSMC (right) for the same set of 5,000 variants. Data were simulated under a neutral coalescent model with sample size *N* = 1,000, effective population size *N*~*e*~ = 10,000, and with constant and equal rates of mutation (*μ* = 1 × 10^−8^) and recombination (*r* = 1 × 10^−8^) per site per generation. Variants were sampled uniformly from a 100-Mb chromosome, with allele count 1 \< *x* \< *N*. Colors indicate relative density (scaled by the maximum per panel). Upper inserts indicate the fraction of sites where the point estimate (mode of the composite posterior distribution) of allele age lies above the upper age of the branch on which it occurred (\^), below the lower age (˅), or within the age range of the branch (∘). Lower inserts indicate the Spearman rank correlation statistic *ρ*, squared Pearson correlation coefficient (on log scale) *r*^2^, interval-adjusted bias metric (see [S2 Text](#pbio.3000586.s015){ref-type="supplementary-material"}) *ε*, and RMSLE. Also shown is an LOESS fit (second-degree polynomials, neighborhood proportion *α* = 0.25; dashed line). (B) The relationship between true and inferred ages for 5,000 variants sampled uniformly from a simulation under a complex demographic model with *N* = 1,000, *N*~*e*~ = 7,300, *μ* = 2.35 × 10^−8^, and variable recombination rates from human chromosome 20 (63 Mb). Allele age was estimated on haplotype data as simulated and without error (top), with error generated from empirical estimates of sequencing errors (middle), and with additional error arising from in silico haplotype phasing; see [S2 Text](#pbio.3000586.s015){ref-type="supplementary-material"}. Allele age was estimated using scaling parameters as specified for each simulation. A further breakdown of results using mutation and recombination clocks alone, as well as the inferred pairwise TMRCAs, is available for A ([S1 Fig](#pbio.3000586.s001){ref-type="supplementary-material"}) and B ([S2 Fig](#pbio.3000586.s002){ref-type="supplementary-material"}, [S3 Fig](#pbio.3000586.s003){ref-type="supplementary-material"}, [S4 Fig](#pbio.3000586.s004){ref-type="supplementary-material"}). GEVA, Genealogical Estimation of Variant Age; HMM, hidden Markov model; LOESS, locally estimated scatterplot smoothing; PSMC, pairwise sequentially Markovian coalescent; RMSLE, root mean-square log~10~ error; TMRCA, time to the most recent common ancestor.](pbio.3000586.g002){#pbio.3000586.g002}

We found that PSMC-based age estimations performed similarly well to GEVA (*ρ* = 0.952), though the time discretization increased bias (*ε* = 0.530) and, in particular, led to overestimation of the age for the youngest variants. We note that PSMC was not designed strictly for this purpose and hence is not optimized for estimating allele age. Conversely, pairwise estimates of the TMRCA between concordant haplotypes were highly correlated with true TMRCA in both GEVA (*ρ* = 0.922) and PSMC (*ρ* = 0.919), but the correlation for discordant pairs was lower in GEVA (*ρ* = 0.586) compared to PSMC (*ρ* = 0.766); see [S1 Fig](#pbio.3000586.s001){ref-type="supplementary-material"}. Such differences in relation to estimating allele age with high accuracy are tolerated because the time of mutation is estimated from the composite distribution of TMRCA posteriors from many pairwise comparisons performed at a single locus. Events that occurred distant in time (relative to the time of mutation) will have little influence on the estimate.

Under a complex demographic model that recapitulates the human expansion out of Africa and with empirical and variable recombination rates, age estimation in GEVA maintained a similarly high level of accuracy (*ε* = 0.198, *ρ* = 0.937; [Fig 2B](#pbio.3000586.g002){ref-type="fig"}). In this situation, although PSMC modeled the more dynamic demographic histories between haplotypes with higher accuracy (correlation of true and inferred TMRCA for discordant pairs: *ρ* = 0.915) compared to GEVA (*ρ* = 0.775), the time discretization resulted in artifacts at more recent times (TMRCA for concordant pairs: *ρ* = 0.892) that were not present in GEVA (*ρ* = 0.932), leading to worse performance when estimating the age (*ε* = 0.409, *ρ* = 0.900; [S2 Fig](#pbio.3000586.s002){ref-type="supplementary-material"}), with the addition of substantial computational cost. We next introduced realistic data complications by reproducing empirically estimated genotype errors in simulated data (see [S2 Text](#pbio.3000586.s015){ref-type="supplementary-material"}), as well as errors arising through in silico haplotype phasing ([Fig 2B](#pbio.3000586.g002){ref-type="fig"}). We found age estimation in GEVA to remain largely unbiased and strongly correlated with true age after the inclusion of data error (*ε* = 0.346, *ρ* = 0.925; [S3 Fig](#pbio.3000586.s003){ref-type="supplementary-material"}) and after phasing (*ε* = 0.430, *ρ* = 0.921; [S4 Fig](#pbio.3000586.s004){ref-type="supplementary-material"}). The PSMC-based approach continued to show higher bias and reduced correlation at the same set of variants, both after error (*ε* = 1.042, *ρ* = 0.882) and after phasing (*ε* = 1.009, *ρ* = 0.880). Reduced data quality resulting from sequencing errors may introduce false signals of pairwise differences seen between haplotypes, and phasing errors may lead to an underestimation of haplotype lengths at variants that are relatively young, for which we overestimate TMRCA and hence allele age (particularly for alleles younger than approximately 100 generations).

Age of selected variants {#sec004}
------------------------

To evaluate the performance of GEVA on empirical data, we first considered variants affecting the well-studied lactase persistence (LP) trait, for which numerous approaches, including the use of archaeological data, genetic data, and a biological understanding of the functional and evolutionary impact of previously associated variants, have resulted in consensus expectations for the age. The *LCT* gene encodes the lactase enzyme but is regulated by variants in an intron of the neighboring *MCM6* gene (Minichromosome Maintenance Complex Component 6). We estimated the age of the derived T allele of the rs182549 variant (G/A-22018), which is at a frequency of approximately 50% in European populations and forms part of a haplotype associated with LP \[[@pbio.3000586.ref033]\]. Under a model that jointly considers mutational and recombinational information, we estimated the allele to be 688 generations old ([Fig 3A](#pbio.3000586.g003){ref-type="fig"}), originating approximately 14,000 to 21,000 years ago, depending on assumptions about generation time in humans \[[@pbio.3000586.ref034], [@pbio.3000586.ref035]\]. Our estimate is based on data from two different sources, the 1000 Genomes Project (TGP) \[[@pbio.3000586.ref002]\] and the Simons Genome Diversity Project (SGDP) \[[@pbio.3000586.ref036]\], which, when estimated separately, give very similar ages (692 and 687 generations, respectively). The full result data set for this variant is available online: <https://human.genome.dating/snp/rs182549>. We obtained a similar age estimate of 693 generations for the derived A allele of the rs4988235 (C/T-13910) variant (see <https://human.genome.dating/snp/rs4988235>), which is also strongly associated with LP and in near perfect association with rs182549, though we note that there is evidence for multiple origins of the variant \[[@pbio.3000586.ref037]\]. Previous estimates of the age of these variants range between 2,200 and 21,000 years \[[@pbio.3000586.ref038]\], putting our estimates on the higher end of this range. Multiple sources of information suggest that these variants only achieved high frequency in European populations within the last 10,000 years (approximately 400 generations) \[[@pbio.3000586.ref039]\] and that LP alleles were rare until the advent of dairy farming in Europe \[[@pbio.3000586.ref040]\]. Our results therefore suggest that the mutation conferring the strongly selected phenotype (estimated to have a selection coefficient of up to 15% in European and up to 19% in Scandinavian populations \[[@pbio.3000586.ref039]\]) was present for hundreds of generations before its rapid sweep through the population.

![Application of GEVA to 3 variants of phenotypic and selective importance.\
(A) Estimated TMRCAs for concordant (left) and discordant (right) pairs of chromosomes for the derived T allele at rs182549, which lies within an intron of *MCM6* and affects regulation of *LCT* \[[@pbio.3000586.ref033]\], which encodes lactase. Each bar reflects the approximate 95% credible interval (ETPI) for a pair, ordered by posterior mean (black dots). Data from the TGP (green) \[[@pbio.3000586.ref002]\] and the SGDP (orange) \[[@pbio.3000586.ref036]\] were used. The frequency of the variant in the SGDP, the TGP, and the different population groups in the TGP is shown (top left). The inferred allele age in generations from each data source and the combined estimate are shown (bottom right) and converted to an approximate age in years, assuming 20--30 years per generation. See <https://human.genome.dating/snp/rs182549> for additional results. (B) As for panel A for the derived G allele of rs3827760, which encodes the Val370Ala variant in *EDAR* and is associated with sweat and facial and body morphology \[[@pbio.3000586.ref041], [@pbio.3000586.ref042]\]; also see <https://human.genome.dating/snp/rs3827760>. Our filtering approach is to remove the smallest number of concordant and discordant pairs necessary (shown in pink) to obtain concordant and discordant sets with nonoverlapping mean posterior TMRCAs. (C) As for panel A for the derived C allele of rs80194531, which encodes the Asn78Thr substitution in *ZEB1*, reported as pathogenic for corneal dystrophy \[[@pbio.3000586.ref043]\]; also see <https://human.genome.dating/snp/rs80194531>. Abbreviations refer to ancestry groups. AFR, African; AMR, American; EAS, East Asian; *EDAR*, Ectodysplasin A Receptor gene; ETPI, equal-tailed probability interval; EUR, European; GEVA, Genealogical Estimation of Variant Age; *LCT*, Lactase gene; *MCM6*, Minichromosome Maintenance Complex Component 6 gene; SAS, South Asian; SGDP, Simons Genome Diversity Project; TGP, 1000 Genome Project; TMRCA, time to the most recent common ancestor; *ZEB1*, Zinc finger E-box--binding homeobox 1 gene.](pbio.3000586.g003){#pbio.3000586.g003}

We next considered the protein-coding missense variant rs3827760 in the Ectodysplasin A Receptor (*EDAR*) gene, where the derived G allele (Val370Ala substitution) is found at high frequency in East Asian populations (87% in the TGP, 82% in the SGDP) and American populations (39% and 80%, respectively) and is associated with sweat, facial and body morphology, and hair phenotypes \[[@pbio.3000586.ref041], [@pbio.3000586.ref042]\]. We estimated the variant to be 1,456 generations old, approximately 29,000 to 44,000 years ([Fig 3B](#pbio.3000586.g003){ref-type="fig"}; <https://human.genome.dating/snp/rs3827760>), again with strong concordance between the TGP (1,513 generations) and the SGDP (1,346 generations). Our estimate is consistent with previous estimates and limited evidence from ancient DNA studies \[[@pbio.3000586.ref007], [@pbio.3000586.ref044]\]. Our results further show that most individuals carrying the allele share a common ancestor close to the time the allele arose through mutation. This may suggest that the variant rapidly rose in frequency following its origin, which is consistent with previous findings of strong positive selection of this variant in East Asia \[[@pbio.3000586.ref041]\]. We compared this result to variants of similar age (1,450 ± 100 generations) in the Atlas of Variant Age (see further below): we found 1,043,376 variants dated in the TGP, of which 2,073 have reached a frequency higher than 30% globally and only 130 above 80% in East Asian populations, demonstrating how unusual such a rapid rise in frequency is.

Finally, we considered the variant rs80194531, in which the derived allele causes an Asn78Thr substitution in the Zinc finger E-box--binding homeobox 1 (*ZEB1*) gene. The variant is reported as pathogenic for corneal dystrophy \[[@pbio.3000586.ref043]\] but is present at 6% in African ancestry samples within the TGP or the SGDP. We estimated the age of the variant to be 5,866 generations old (120,000 to 180,000 years), again with consistency between the TGP and the SGDP (5,879 and 5,854 generations, respectively; [Fig 3C](#pbio.3000586.g003){ref-type="fig"}; <https://human.genome.dating/snp/rs80194531>). Such an ancient age seems inconsistent with the reported dominant pathogenic effect \[[@pbio.3000586.ref043]\]. Moreover, of the 1.2 million variants found at comparable frequencies (5%--7%) in African ancestry individuals within the TGP, we found that 46% were estimated to be younger than the rs80194531 allele, suggesting that this variant is in no way unusual.

Distribution of allele age in the human genome {#sec005}
----------------------------------------------

We next sought to characterize the age distribution of genetic variation across the human genome, for which we applied GEVA to more than 45 million variants identified in the TGP or the SGDP. More than 32 billion haplotype pairs were analyzed to estimate shared haplotype segments and TMRCAs. For variants present in both data sources (13.7 million), we additionally estimated the age by combining pairwise TMRCA distributions that were inferred independently in each sample after confirming that separately obtained age estimates agreed (Spearman's *ρ* = 0.862; see [S5 Fig](#pbio.3000586.s005){ref-type="supplementary-material"}). We make this information, referred to as the Atlas of Variant Age for the human genome, publicly available as an online database ([https://human.genome.dating](https://human.genome.dating/)). A breakdown by chromosome of the number of variants dated and haplotype pairs analyzed is given in [S1 Table](#pbio.3000586.s009){ref-type="supplementary-material"}. Further details are given in [S3 Text](#pbio.3000586.s016){ref-type="supplementary-material"}.

We find substantial variation in the relationship between estimated age and allele frequency, depending on the population in which frequency is measured and the geographical distribution of the variant ([Fig 4A](#pbio.3000586.g004){ref-type="fig"}). Variants in African ancestry groups are typically older than in other groups and also have the greatest variance in age for a given frequency. For example, variants below 0.5% (within a given population) have a median age of 670 generations in African ancestry groups, 377 generations in East Asian ancestry groups, and 488 generations in Europeans (see [S2 Table](#pbio.3000586.s010){ref-type="supplementary-material"}). The age distribution of variants restricted to a particular ancestry group (or shared between them) indicates the degree of connection between populations. For example, there are many variants up to 5,000 generations old (100,000 to 150,000 years) that are restricted to African ancestry groups yet are observed at frequencies up to 10%, but variants in this frequency range that are restricted to East Asian or South Asian ancestry groups are typically under 1,000 generations (20,000 to 30,000 years) or 1,300 generations old (26,000 to 39,000 years), respectively. Conversely, cosmopolitan variants that are shared among every ancestry group are typically older than 2,000 generations (40,000 to 60,000 years) despite being observed at global frequencies below 0.5% ([S6 Fig](#pbio.3000586.s006){ref-type="supplementary-material"}). Variants restricted to American ancestry groups are typically younger than 750 generations (15,000 to 22,500 years), consistent with existing knowledge about the settlement of the Americas via the Bering land bridge that connected Asia and North America during the last glacial maximum around 15,000 to 23,000 years ago \[[@pbio.3000586.ref045], [@pbio.3000586.ref046]\]. We note, however, that recent admixture and the sampling strategies of the different data sets \[[@pbio.3000586.ref047], [@pbio.3000586.ref048]\] can have a strong impact on age distributions. For example, variants at high frequency within American populations but that are nevertheless restricted to just American and African populations are, on average, younger than lower-frequency variants (within American populations) with the same geographical restriction ([S6 Fig](#pbio.3000586.s006){ref-type="supplementary-material"}). These variants likely arose recently within Africa and entered American populations through admixture, rising to high frequency through population bottlenecks \[[@pbio.3000586.ref049]\]. Similarly, variants found only within European and African populations but that have a frequency below 0.5% in Europeans are, on average, older than variants observed at higher frequencies in Europeans and older than variants restricted to only Europeans in the same frequency range, suggesting recent gene flow from Africa into Europe.

![Age distribution of variants among different human populations.\
(A) The relationship between estimated allele age and frequency as observed within a given population group in the TGP sample. Of the 45.4 million variants available in the Atlas of Variant Age, 43.2 million were dated using TGP data alone; we excluded variants with low estimation quality and inconsistent ancestral allele information (see [S3 Text](#pbio.3000586.s016){ref-type="supplementary-material"}), retaining 34.4 million variants. Each line shows the cumulative age distribution of variants within a given frequency bin (see legend) within a population group; circles indicate median and interquartile range. Panels on the left show the frequency-stratified cumulative distribution of estimated age for variants at nonzero frequencies as observed within a given ancestry group. The number of variants available per group is shown (top left). Panels on the right show the distributions of geographically restricted variants that only segregate within a group (number of available variants shown on bottom right). A summary of variants shared between different ancestry groups in the TGP is provided in [S6 Fig](#pbio.3000586.s006){ref-type="supplementary-material"}. (B) Differences in allele age distributions for approximately 70,000 variants in the TGP that are annotated as impacting protein function by PolyPhen-2 (left) and SIFT (right), compared to a reference set of variants (those annotated as benign by PolyPhen-2 or tolerated by SIFT), matched for allele frequency within a given ancestry group. These results are presented in more detail in [S7 Fig](#pbio.3000586.s007){ref-type="supplementary-material"}. AFR, African; AMR, American; EAS, East Asian; EUR, European; PolyPhen-2, Polymorphism Phenotyping v2 software; SAS, South Asian; SIFT, Sorting Intolerant From Tolerant software; TGP, 1000 Genomes Project.](pbio.3000586.g004){#pbio.3000586.g004}

Such heterogeneity in the relationship between allele age and frequency, coupled with heterogeneous and unknown sampling strategies, complicates the use of frequency as a means of assessing variants for potential pathogenicity during the interpretation of individual genomes. The Atlas of Variant Age potentially offers a more direct approach for screening variants, given the high probability of elimination of nonrecessive deleterious variants within a few generations \[[@pbio.3000586.ref050]\]. To assess the value of allele age in the interpretation of potentially pathogenic variants, we estimated the ages of variants that had effects predicted as damaging by Polymorphism Phenotyping v2 software (PolyPhen-2) \[[@pbio.3000586.ref051]\] or deleterious by Sorting Intolerant From Tolerant software (SIFT) \[[@pbio.3000586.ref052]\] in the TGP ([Fig 4B](#pbio.3000586.g004){ref-type="fig"}). Of the approximately 70,000 variants analyzed, 50% of damaging and 49% of deleterious variants were estimated to have arisen within the last 500 generations (10,000 to 15,000 years), compared to 41% of benign (PolyPhen-2) and 42% of tolerated (SIFT) variants ([S7 Fig](#pbio.3000586.s007){ref-type="supplementary-material"}). Compared with control sets of variants (those annotated as benign or tolerated and matched for allele frequency within the focal ancestry group), variants annotated as damaging or deleterious had a notable dearth of older variants (\>1,000 generations) for a given frequency, consistent with theoretical expectations and previous findings \[[@pbio.3000586.ref019], [@pbio.3000586.ref053], [@pbio.3000586.ref054]\]. Our results suggest that old alleles can largely be excluded from consideration of pathology (though recent origin is not evidence in favor of pathogenicity).

Shared ancestry {#sec006}
---------------

Finally, we investigated the extent to which patterns of sharing of variants of different ages could power approaches for learning about genealogical history. Previous work has highlighted the descriptive value of genetic variants in identifying individuals who share recent common ancestry and patterns of demographic isolation and migration \[[@pbio.3000586.ref010], [@pbio.3000586.ref055], [@pbio.3000586.ref056]\], though it has also highlighted the challenges of interpreting the output of approaches such as principal component analysis (PCA) \[[@pbio.3000586.ref057], [@pbio.3000586.ref058]\]. Conversely, numerous model-based approaches have been developed that use patterns of variant and haplotype sharing to infer underlying demographic parameters \[[@pbio.3000586.ref014], [@pbio.3000586.ref059]--[@pbio.3000586.ref061]\], though these typically make strong simplifying assumptions about the space of possible histories.

Here, we present a nonparametric approach for combining descriptive and inferential approaches to learn about ancestral connections between individual genomes (and groups of individuals) based on variant age information. Unlike existing methods that assign time-invariant ancestry proportions to individual genomes by reference to contemporary populations \[[@pbio.3000586.ref009], [@pbio.3000586.ref062]\], we can estimate the fraction a given genome shares because of common ancestry with any other genome at different points in time, referred to as the cumulative coalescent function (CCF). We use a fast dynamic-programming approach to estimate a maximum likelihood CCF between any pair or group of individuals ([Fig 5A](#pbio.3000586.g005){ref-type="fig"}; see [S4 Text](#pbio.3000586.s017){ref-type="supplementary-material"}). Using simulated data, we found that inference of ancestral relationships between individuals (CCFs inferred from estimated allele ages) correctly reflected differences of relatedness among individuals within and between different ancestry groups and revealed patterns qualitatively consistent with past demographic events (see [S5 Text](#pbio.3000586.s018){ref-type="supplementary-material"}), though we note that uncertainty in variant age estimates may cause oversmoothing of coalescent profiles, in particular in the distant past (\>20,000 generations ago).

![Age-stratified variant sharing to characterize ancestral relatedness.\
(A) Overview of approach for estimating the CCF for a pair of haplotypes, the fraction of the genomes of the two samples that have coalesced by a given time. Derived variants within a target genome are identified, their estimated ages are obtained from the Atlas of Variant Age, and their presence (black circles) or absence (white circles) in another (comparator) genome of interest is recorded. Variants are sorted by allele age (indicated by color), *t*, to obtain a naive maximum likelihood estimate of the CCF, Λ(*t*), using dynamic programming (assuming independence of variants and ignoring error in variant age estimates). (B) Selected pairwise CCFs for the two haploid genomes (chromosome 5) of individual HG00733 (top: maternally derived; bottom: paternally derived) of a Puerto Rican individual from the TGP compared to 8 haplotypes from 4 individuals, including their mother and father. Maternal and paternal genomes were used for phasing; hence, the inferred parental genomes are the transmitted (and untransmitted) genomes. The CCFs inferred with genomes from the entire TGP sample is shown in [S1 Movie](#pbio.3000586.s011){ref-type="supplementary-material"}. The full result data set for HG00733 is available at <https://human.genome.dating/ancestry/HG00733>. (C) Inferred genome-wide CCFs (averaged per diploid individual across autosomes) for a Siberian Eskimo from the SGDP (ID: S_Eskimo_Sireniki-1) to all other sampled individuals (top panel). Colors indicate ancestry by geographic region (see legend). The CCF can also be expressed as a CIF (middle panel) to reflect the increase in shared ancestry within a given time period. Each row represents an individual from the SGDP, ordered by the AUC of the CCF and scaled such that the maximum per column is equal to one. The color bar (right) indicates the ancestry group of sorted individuals. The CIF within any time epoch can be expressed as an effective population size (*N*~*e*~ equivalent) from the maximum over reference samples, providing a summary of the rate at which common ancestor events occurred (bottom panel). The full result data set for this individual is available at <https://human.genome.dating/ancestry/S_Eskimo_Sireniki-1>. AFR, African; AMR, American; AUC, area under the curve; CCF, cumulative coalescent function; CIF, coalescent intensity function; EUR, European; SGDP, Simons Genome Diversity Project; TGP, 1000 Genomes Project.](pbio.3000586.g005){#pbio.3000586.g005}

To illustrate the value of this nonparametric approach in describing the history of individuals and groups, we first considered the coalescent history between a single individual of American (Puerto Rican) ancestry from the TGP (ID: HG00733) and all others in the TGP sample, using GEVA age estimates for variants on chromosome 5 ([Fig 5B](#pbio.3000586.g005){ref-type="fig"}). As a positive control, we included the parents of HG00733 (HG00732 and HG00731), who reach a CCF of near 1 in the most recent epoch (though note that the parents were used for haplotype phasing, which estimates transmitted haplotypes; hence the CCF reaching 1 rather than the expected one-half). We show the ancestry of HG00733 shared with every individual in the TGP sample in [S1 Movie](#pbio.3000586.s011){ref-type="supplementary-material"}; also see <https://human.genome.dating/ancestry/HG00733>. Within the first 100 generations, we see additional coalescence with the untransmitted parental chromosomes and other individuals from the Puerto Rican sample. The earliest common ancestry outside Puerto Rico is seen with a European individual in Spain (paternal side; approximately 60 generations ago) and a Mexican ancestry individual (maternal side; approximately 80 generations ago). Coalescence with individuals sampled from outside the Americas occurs further back in time (\>100 generations ago), initially with European individuals (predominantly around 300 to 600 generations ago), then uniformly with non-African individuals around 1,500 to 4,000 generations ago, more strongly with African individuals around 5,000 to 15,000 generations ago, and uniformly with all individuals around 20,000 generations ago. Because of the impact of data errors on age estimation of recent variants (highlighted above), the absolute timings of the early events are likely substantially overestimated. However, we expect the relative ordering of events to be robust and consistent among sample comparisons (see [S5 Text](#pbio.3000586.s018){ref-type="supplementary-material"}).

The CCFs to all other members of a reference panel (averaged across all chromosomes in both haploid genomes) provide an overview of the genealogical relationships for a target individual. As an example, we inferred the CCF profiles of a Siberian Eskimo to all other individuals in the SGDP ([Fig 5C](#pbio.3000586.g005){ref-type="fig"}, top), showing common ancestry to other Central Asian and Siberian individuals within a few hundred generations, substantial common ancestry with American individuals before 1,000 generations, and typically more recent common ancestry with East Asians than West Eurasians or Africans; see <https://human.genome.dating/ancestry/S_Eskimo_Sireniki-1>. Notably, relatively little additional coalescence is seen during a period around 2,000 to 10,000 generations ago, which is a pattern shared among non-African individuals (also see [S1 Movie](#pbio.3000586.s011){ref-type="supplementary-material"}) and agrees with previous findings of a period of reduced coalescence, peaking 100,000 to 200,000 years ago \[[@pbio.3000586.ref014]\].

The CCF can also be represented as a coalescent intensity function (CIF; see [S4 Text](#pbio.3000586.s017){ref-type="supplementary-material"}), which measures the rate of change of common ancestry over time ([Fig 5C](#pbio.3000586.g005){ref-type="fig"}, middle). The CIF reveals additional structure; for example, around 3,000 to 20,000 generations ago, those parts of the Siberian Eskimo\'s genome that have not yet coalesced with other genomes sampled from the same ancestry group have a very low CIF, while the CIF to the African ancestry samples (which have had very little coalescence until this point) is relatively high (though note the absolute rate remains very low over this period).

We can further summarize the coalescent profiles for the target individual by computing the maximum CIF over the sample. This statistic captures properties analogous to the effective population size parameter, *N*~*e*~, in population genetics modeling, in which the expected coalescent intensity is inversely related to population size. We refer to the maximum CIF in the following as the *N*~*e*~ equivalent ([Fig 5C](#pbio.3000586.g005){ref-type="fig"}, bottom), though we note that (in the case in which there are genuine populations) it is likely to be downward biased compared to existing methods; for example, we would expect PSMC \[[@pbio.3000586.ref013]\] to infer absolute values of ancestral population size more accurately. We therefore use *N*~*e*~ equivalents to provide a relative summary of genealogical histories across the entire cohort.

We estimated all pairwise CIFs in TGP ([S2 Movie](#pbio.3000586.s012){ref-type="supplementary-material"}), which we aggregated across autosomes to generate a coalescent profile between each pair of individuals (see [S6 Text](#pbio.3000586.s019){ref-type="supplementary-material"}). Likewise, we estimated the ancestry shared between each individual pair in SGDP ([S3 Movie](#pbio.3000586.s013){ref-type="supplementary-material"}); CIFs were further aggregated among the 130 population groups ([Fig 6](#pbio.3000586.g006){ref-type="fig"}). These reveal how the rates and structure of coalescence have changed over time, with the most recent epoch (up to approximately 200 generations ago) dominated by coalescence within populations, but also identify recent connections between groups such as between southern Siberian and northern East Asian populations ([Fig 6A](#pbio.3000586.g006){ref-type="fig"}). Several populations such as the Kusunda (Nepal), Saami (Finland), and Negev Bedouins (Israel) show strong within-group coalescence up to this point, though by 500 generations ago they are coalescing primarily with other populations. The epoch around 800 generations ago is dominated by structure broadly corresponding to the continental level ([Fig 6B](#pbio.3000586.g006){ref-type="fig"}), though some African populations---for example, the Mbuti (Congo), but more dramatically the Khomani San (South Africa) and Ju\'hoansi (Namibia)---remain isolated up to approximately 1,500 generations ago (30,000 to 45,000 years), which overlaps with previous findings \[[@pbio.3000586.ref063]\], and we see these two populations to be strongly connected for an extended period further back in time ([S3 Movie](#pbio.3000586.s013){ref-type="supplementary-material"}). Around 800 generations ago, there is very little remaining structure among West Eurasian populations, but many additional intercontinental connections are now identified. For example, we see a north-to-south gradient of decreasing coalescence between American populations and Siberian or East Asian populations. In particular, we identify strong coalescence of American ancestry individuals with Siberian Eskimos, Aleutian Islanders, and Tlingit people in a period between 500 and 1,000 generations ago and very little structure among American, Siberian, and East Asian populations as a whole further back than 1,000 generations ago ([S3 Movie](#pbio.3000586.s013){ref-type="supplementary-material"}), which agrees with previous results regarding the human migration into the Americas, extended isolation, and subsequent dispersal across the continent \[[@pbio.3000586.ref046]\]. By 4,000 generations ago, we see high levels of coalescence between non-African and African populations ([Fig 6C](#pbio.3000586.g006){ref-type="fig"}) and essentially no structure in the epoch around 20,000 generations ago ([Fig 6D](#pbio.3000586.g006){ref-type="fig"}). We note that the exact timings of demographic events (signified by periods of intense or reduced coalescence), while showing consistent patterns within and among population groups, may carry additional noise due to uncertainty in allele age estimates.

![Age-stratified connections between ancestry groups in the publicly available SGDP sample.\
The CCF was inferred for all 556 haploid target genomes with all other comparator genomes in the SGDP sample and then aggregated by ancestry group (mean of CCFs from individuals within a population) and across chromosomes, with populations as defined in the SGDP (see legend on the right). (A--D) The ancestry shared between populations is indicated by the CIF over a given time interval (epoch), shown as a matrix with populations sorted from north to south within continental regions. Intensities were computed from aggregated CCFs to summarize relationships between populations; colors indicate intensity scaled per target population (rows) by the maximum over comparator populations. Ancestral connections are shown at different epochs back in time; around 200 generations ago (A), 800 generations (B), 4,000 generations (C), and 20,000 generations (D). The conversion (top right) assumes 20--30 years per generation. A more detailed summary, showing the ancestry shared between individuals, over a sliding time window (epoch) is shown in [S3 Movie](#pbio.3000586.s013){ref-type="supplementary-material"}. (E) The maximum CIF for individuals from different ancestry groups (continental regions) expressed as effective population size (*N*~*e*~) equivalents over time, estimated from CCFs aggregated per diploid individual and summarized by the median and interquartile range per group. Triangles indicate the epochs shown in panels A--D. A further breakdown of *N*~*e*~ equivalents estimated from nonaggregated CCFs per chromosome is shown in [S8 Fig](#pbio.3000586.s008){ref-type="supplementary-material"}. CCF, cumulative coalescent function; CIF, coalescent intensity function; SGDP, Simons Genome Diversity Project.](pbio.3000586.g006){#pbio.3000586.g006}

The maximum CIF profiles (*N*~*e*~ equivalents; [Fig 6E](#pbio.3000586.g006){ref-type="fig"}) highlight several features, including differences among modern ancestry groups in the intensity of coalescence within the last 1,000 generations (particularly intense for American and Oceanic populations); a major period of intense coalescence among all non-African ancestry individuals around 1,000 to 2,000 generations ago, following the migration of modern humans out of Africa \[[@pbio.3000586.ref064]\]; a weaker, but still marked, increase in coalescent intensity for African ancestry samples around 2,000 generations ago; and an older reduction in coalescent intensity, peaking around 5,000 to 8,000 generations ago, potentially driven by ancient population structure within Africa and (for non-African populations) possible admixture with archaic lineages \[[@pbio.3000586.ref065]--[@pbio.3000586.ref067]\]. We find minor quantitative, but not qualitative, differences among chromosomes ([S8 Fig](#pbio.3000586.s008){ref-type="supplementary-material"}). We note that the bottleneck and steep change in population size around 60,000 to 80,000 generations ago, although consistent across ancestry profiles inferred for all individuals in the sample, is likely to be an artifact possibly caused by decreased accuracy of age estimates in the distant past, along with a breakdown of assumptions regarding the statistical independence of very old mutations.

Discussion {#sec007}
==========

We have demonstrated how allele age estimates can provide insight to a range of problems in statistical and population genetics. However, there are several important assumptions and limitations of the approach. First, a key assumption is that of a single origin for each allele. Given the size of the human population and the mutation rate, it is likely that every allele has arisen multiple times over evolutionary history. Yet, unless the mutation rate is extremely high, it is still probable that most individuals carrying the allele do so through common ancestry. Moreover, multiple origins can potentially be identified through the presence of the allele on multiple haplotype backgrounds, as has, for example, been seen for the rs4988235 variant at *LCT* \[[@pbio.3000586.ref037]\] (though we note that a previous study \[[@pbio.3000586.ref068]\] concluded that the allele of variant rs4988235 was brought into African populations through historic gene flow, possibly through the Roman Empire), the O blood group \[[@pbio.3000586.ref069]\], or alleles in the Human Leukocyte Antigene (*HLA*) region \[[@pbio.3000586.ref070]\]. A variant lying in a region with high rates of noncrossover (gene conversion) may similarly be found on multiple haplotype backgrounds \[[@pbio.3000586.ref071]\]. However, for genomes with very high mutation rates, such as HIV-1 \[[@pbio.3000586.ref072]\], recurrence is sufficiently high to make estimates of allele age meaningless. In addition, while we have shown GEVA to be robust to realistic levels of sequencing and haplotype phasing error, the actual structures of error found in reference data sources, such as the TGP, have additional complexity whose effect is unknown \[[@pbio.3000586.ref073]\].

Our approach also assumes a known and time-invariant rate of recombination. For most species, only indirect estimates of the per-generation recombination rate are available, and in humans \[[@pbio.3000586.ref074]\] and mice \[[@pbio.3000586.ref075]\], there is evidence for evolution in the fine-scale location of recombination hotspots through changes in the binding preferences of *PRDM9* (PR domain zinc finger protein 9). However, because broad-scale recombination rates evolve at a much lower rate than hotspot location \[[@pbio.3000586.ref076]\] and because our approach for detecting recombination events is driven largely by the presence of recombinant haplotypes, we expect GEVA to be relatively robust for recent variants. Older variants may be more affected, but for such variants, most information comes from the mutation clock, which is likely to have been more stable over time.

We have shown that the ages of variants are highly correlated when estimated separately in independent samples, which agrees with the assumption that, for the majority of alleles, mutations occurred only once in the history of the population, such that the true age of an allele refers to a fixed point in time. In principle, the age can be estimated irrespective of the frequency distribution observed in different study cohorts. Our results show substantial heterogeneity in the relationship between frequency and age, revealing the impact of often unknown demographic variables on the distribution of alleles within and across different ancestry groups, which may further be confounded by the mode and strength of selection on particular alleles. The estimation profiles of variants shown in [Fig 3](#pbio.3000586.g003){ref-type="fig"} provide only a few examples of cases in which the frequency may not be reliable as a proxy for the age. Our method and the Atlas of Variant Age may therefore provide more robust measures for analyses that otherwise rely on population or sample-specific allele frequencies.

The Atlas of Variant Age also has multiple applications beyond statistical and population genetics. For example, recent variants provide a natural index when searching for related samples in population-scale data sets. We have demonstrated how variant age information can be leveraged more comprehensively, using a nonparametric approach, to learn about genealogical history, relatedness between individuals, and ancestral connections between populations. Our approach to infer coalescent profiles (pairwise CCF and sample-wide CIF) captures ancestry proportions and coalescence rate variations as a function of time, from which we can distinguish recent from past demographic effects or estimate changes of relative relatedness over time. As illustrated for whole-genome sequencing data from the TGP and SGDP, our methodology accesses a time dimension to study relatedness between individual genomes and among entire sample cohorts. Applications to other data sets may use information from the Atlas of Variant Age without the need to re-estimate ages, thus demonstrating the value of this resource for exploratory data analysis.

Finally, as presented here, it is possible to combine information from multiple, potentially even distributed data sets by estimating coalescent time distributions for pairs of concordant and discordant haplotypes in each data resource separately or to update age estimates by the inclusion of additional samples. Estimation of the age of particular variants may gain additional accuracy by increasing the number of pairwise comparisons, depending on the history of the allele and the genealogical resolution attainable from the diversity of ancestral backgrounds inherent to available sample data. Future studies may reveal new variants, particularly within under-represented ancestry groups, that can also be added to the Atlas of Variant Age. The methods are also applicable to nonhuman species as long as estimates of mutation rate, recombination rate, and generation time are available. Future extensions to infer location of origin or the ancestral haplotype, integrating the growing wealth of genome data from ancient samples, will be an important step towards reconstructing the ancestral history of the entire species.

Materials and methods {#sec008}
=====================

Data sources {#sec009}
------------

Estimation of allele age and shared ancestry was conducted on publicly available data sets: the TGP \[[@pbio.3000586.ref002]\] and the SGDP \[[@pbio.3000586.ref036]\]. We used phased haplotype data of chromosomes 1--22 from the final release TGP panel (Phase 3; GRCh37), available for 2,504 individuals from 26 populations worldwide (5 continental population groups). Additional data were available from the TGP for 31 related individuals, which we included in our shared ancestry analysis. We used phased haplotype data of chromosomes 1--22 from the publicly available SGDP panel (PS2; GRCh37), consisting of 278 individuals from 130 populations worldwide (7 continental population groups). Recombination rates were determined for each chromosome using the genetic maps available from the International HapMap Project (Phase 2; GRCh37) \[[@pbio.3000586.ref078]\]. Genotype data from the Illumina Platinum Genomes Project (IPG) \[[@pbio.3000586.ref079]\] (GRCh37; chromosomes 1--22) were used as a reference to measure genotype error in a matched subsample from the TGP. We used information from the Ensembl database (GRCh37; release 92, version 20180221) to determine the ancestral and derived allelic states for variants in both the TGP and SGDP panels, as predicted through multispecies alignments in the Ensembl EPO pipeline.

Availability of results {#sec010}
-----------------------

The Atlas of Variant Age is publicly available as an online database: <https://human.genome.dating/>. It contains the age estimation results for more than 45 million variants in the human genome, including the results of all pairwise analyses conducted at each focal site to estimate shared haplotype segments and infer TMRCA between haplotype pairs (more than 32 billion). We used an HMM to infer shared haplotype segments, for which we constructed an empirical error model (through comparison between genotypes from the IPG and TGP) to generate frequency-dependent emission and initial state probabilities; these are available online: <https://github.com/pkalbers/geva/tree/master/hmm>. Furthermore, we performed shared ancestry analyses for every pair of individual chromosomes in the TGP (including related individuals) and the SGDP, which are also available at <https://human.genome.dating/>.

Source code availability {#sec011}
------------------------

The source code of the GEVA method is available online at <https://github.com/pkalbers/geva>. The source code of the CCF dynamic programming algorithm is available at <https://github.com/pkalbers/ccf>. We modified the original source code of MSMC2 to optimize the performance of the PSMC algorithm in our simulation analysis, available at <https://github.com/pkalbers/msmc2>.

Supporting information {#sec012}
======================

###### Simple demographic model simulation.

Allele age estimation and TMRCA inference in a simulation of a 100-Mb region with sample size *N* = 1,000, effective population size *N*~*e*~ = 10,000, constant mutation rate (*μ* = 1 × 10^−8^ per site per generation), and constant recombination rate (*r* = 1 × 10^−8^ per site per generation). (A) Relationship between the true allele age (geometric mean of lower and upper age of the branch on which a mutation occurred; *x* axis) and estimated allele age (*y* axis), estimated using the mutation clock, recombination clock, and joint clock models (left) and PSMC (right) for the same set of 5,000 variants, randomly sampled at allele count 1 \< *x* \< *N*. Colors indicate the density scaled by the maximum per panel. Upper inserts indicate the fraction of sites where the point estimate (mode of the composite posterior distribution) of allele age lies above the upper age of the branch on which the mutation occurred (\^), below the lower age (˅), or within the range of the branch (∘). Lower inserts indicate the Spearman rank correlation statistic *ρ*, the square of the Pearson correlation coefficient (on log scale) *r*^2^, the interval-adjusted error metric *ε*, and the RMSLE. Also shown is an LOESS fit (second-degree polynomials, neighborhood proportion *α* = 0.25; dashed line). (B) Relationship between true TMRCA for a haplotype pair at a given site and corresponding inferred TMRCA (mean of posterior distribution), shown separately for concordant and discordant pairs. The same sets of haplotype pairs were analyzed under each clock model in GEVA (left) and PSMC (right). Colors indicate the density scaled by the maximum per panel. Lower inserts indicate the Spearman rank correlation statistic *ρ*, the square of the Pearson correlation coefficient (on log scale) *r*^2^, and the RMSLE. GEVA, Genealogical Estimation of Variant Age; LOESS, locally estimated scatterplot smoothing; PSMC, pairwise sequentially Markovian coalescent; RMSLE, root mean-square log~10~ error; TMRCA, time to the most recent common ancestor.

(TIF)

###### 

Click here for additional data file.

###### Complex demographic model simulation without error.

Allele age estimation and TMRCA inference in a simulation that recapitulates the human expansion out of Africa \[[@pbio.3000586.ref077]\], with *N* = 5,000, *N*~*e*~ = 7,300, constant mutation rate *μ* = 2.35 × 10^−8^, and variable recombination rates from HapMap (Phase 2, GRCh37) \[[@pbio.3000586.ref078]\] for chromosome 20 (63 Mb). Allele age was estimated for 5,000 variants sampled uniformly from the intersection of sites available at allele count 1 \< *x* \< *N* in data without error and after data were modified with error; see [S3 Fig](#pbio.3000586.s003){ref-type="supplementary-material"} and [S4 Fig](#pbio.3000586.s004){ref-type="supplementary-material"}. Description of plots as in [S1 Fig](#pbio.3000586.s001){ref-type="supplementary-material"}. GRCh37, Genome Reference Consortium Human Build 37; TMRCA, time to the most recent common ancestor.

(TIF)

###### 

Click here for additional data file.

###### Complex demographic model simulation with error.

Allele age estimation and TMRCA inference from simulated data in which haplotype data were modified with realistic error rates; calibrated from empirical estimates of genotype errors in TGP data \[[@pbio.3000586.ref002]\], by comparison to corresponding genotype data from the IPG \[[@pbio.3000586.ref079]\]. Allele age was estimated for the same set of 5,000 variants as analyzed in [S2 Fig](#pbio.3000586.s002){ref-type="supplementary-material"} and [S4 Fig](#pbio.3000586.s004){ref-type="supplementary-material"}. Description of plots as in [S1 Fig](#pbio.3000586.s001){ref-type="supplementary-material"}. IPG, Illumina Platinum Genomes Project; TGP, 1000 Genomes Project; TMRCA, time to the most recent common ancestor.

(TIF)

###### 

Click here for additional data file.

###### Complex demographic model simulation with error and after phasing.

Allele age estimation from simulated data in which haplotype data were modified with realistic error rates, calibrated from empirical estimates of genotype errors in TGP data \[[@pbio.3000586.ref002]\], by comparison to data from the IPG \[[@pbio.3000586.ref079]\]. Haplotype data were additionally phased using SHAPEIT2 \[[@pbio.3000586.ref080]\] after the introduction of data error. Allele age was estimated for the same set of 5,000 variants as analyzed in [S2 Fig](#pbio.3000586.s002){ref-type="supplementary-material"} and [S3 Fig](#pbio.3000586.s003){ref-type="supplementary-material"}. Description of plots as in [S1 Fig](#pbio.3000586.s001){ref-type="supplementary-material"}. Note that the relationship between true and inferred TMRCA per haplotype pair cannot be ascertained conclusively after phasing of haplotype data. IPG, Illumina Platinum Genomes Project; TGP, 1000 Genomes Project; TMRCA, time to the most recent common ancestor.

(TIF)

###### 

Click here for additional data file.

###### Correlation between allele age estimated separately in TGP and SGDP data.

\(A\) The relationship between allele age using data from the TGP (*x* axis) and the SGDP (*y* axis), estimated from the mutation clock (left), recombination clock (center), and the joint clock model (right), for 13.7 million variants dated in both data sources. Colors indicate the density scaled by the maximum per panel. Lower inserts indicate the Spearman rank correlation statistic *ρ* and the square of the Pearson correlation coefficient (calculated on log-scaled allele ages) *r*^2^. (B) Differences in allele frequency of the variants compared (left); the histograms (right) show the frequencies as observed in the TGP (top) and the SGDP (bottom) for corresponding sets of variants. SGDP, Simons Genome Diversity Project; TGP, 1000 Genomes Project.

(TIF)

###### 

Click here for additional data file.

###### Allele age and frequency for variants shared between different human populations.

The relationship between allele age and frequency for variants dated in the TGP. Allele age was estimated under the joint clock model using TGP data (whole sample). Of the 43.2 million variants dated in the TGP (chromosomes 1--22), we excluded those with low estimation quality and inconsistent ancestral allele information, which retained 34.4 million variants. Allele frequencies were calculated within subsamples of AFR, AMR, EAS, EUR, and SAS ancestry groups, as defined in TGP sample data. Lines in each panel show the cumulative age distribution of variants within a given frequency bin (see legend), with frequencies as observed within the population group indicated at the top (columns); circles indicate median and interquartile range (25th, 50th, and 75th percentiles). (A) The subset of variants observed in only two population groups, referring to sites that have nonzero frequencies in either of the two populations considered and zero frequency in all other groups (white background color), and geographically restricted variants that are isolated within only a single population group, referring to sites that have nonzero frequencies in the population considered and zero frequency in all other groups (diagonal panels; gray background color). Panels that are diagonal opposites show results for the same set of variants but with frequencies as observed in the population considered (by column). The number of variants retained is shown in each panel (bottom right). (B) The age distribution of strictly cosmopolitan variants (nonzero frequencies in every group) by frequency as seen within a population group. The distributions shown in each panel were obtained on same set of 3,634,716 variants. AFR, African; AMR, American; EAS, East Asian; EUR, European; SAS, South Asian; TGP, 1000 Genomes Project.

(TIF)

###### 

Click here for additional data file.

###### Allele age of potentially pathogenic variants.

Allele age was estimated (joint clock) using sample data from the TGP for variants annotated by the Ensembl VEP \[[@pbio.3000586.ref081]\]. We excluded variants with low age estimation quality or inconsistent ancestral allelic states (determined through multispecies alignments; information available through Ensembl), which retained 64,432 (of 70,220) variants annotated by PolyPhen-2 \[[@pbio.3000586.ref051]\] and 61,995 (of 67,539) variants annotated by SIFT \[[@pbio.3000586.ref052]\]; of those, 61,615 (of 67,123) variants have been annotated by both methods. (A) The relationship between allele age and variant effects predicted by PolyPhen-2 (top), with effect categories given as benign, possibly damaging, probably damaging, and unknown; variant numbers per category are indicated in the legend. Each line shows the cumulative age distribution by effect category; circles indicate median and interquartile range. The frequency distribution of all variants considered is shown for the 5 major population groups defined in the TGP sample (middle), given as the number of variants within allele count bins (evenly spaced on linear scale but shown on log scale), with allele count as per population group in the TGP. The number of variants at nonzero frequencies in a population group is indicated in the legend. The relative proportion of variants across effect categories per allele count bin for the 5 major population groups in the TGP (bottom). (B) As for part (A), plots show the relationships between allele age and population frequency for variants predicted by SIFT, with effect categories given as tolerated and deleterious. (C) QQ-plots showing differences in allele age distributions for variants annotated by PolyPhen-2 (left) and SIFT (right), compared to a control set of variants (those annotated as benign by PolyPhen-2 or tolerated by SIFT), matched for allele frequency within a given population group. Matching was done by retaining only those variants observed at nonzero frequency within a population group and if variants of every effect category were represented at identical allele counts. The inset in each panel (bottom right) shows the number of variants retained per effect category. PolyPhen-2, "Polymorphism Phenotyping v2" software; SIFT, "Sorting Intolerant From Tolerant" software; TGP, 1000 Genomes Project; VEP, Variant Effect Predictor.

(TIF)

###### 

Click here for additional data file.

###### Effective population size (*N*~*e*~ equivalent) over time for chromosomes 1--22 in the SGDP.

The CCF was inferred for each haploid target genome with all other comparator genomes in the SGDP sample, based on a total of 11.7 million variants dated (joint clock) on chromosomes 1--22, retained after excluding variants with low age estimation quality and inconsistent ancestral allele information. Coalescent intensity was computed per target genome and scaled by the maximum over the sample at a given time interval (epoch; evenly distributed on log scale). Each line shows the median and interquartile range of *N*~*e*~ equivalents inferred for individuals in the different ancestry groups (continental regions; see legend). CCF, cumulative coalescent function; SGDP, Simons Genome Diversity Project.

(TIF)

###### 

Click here for additional data file.

###### Summary of variants per chromosome in the Atlas of Variant Age.

The table shows the total number (*N*~all~) of variants available in the Atlas of Variant Age on chromosomes 1--22, as well as the number of variants dated using data from the TGP alone (*N*~TGP~) and the SGDP alone (*N*~SGDP~). Additionally, variants present in both data sets were dated using independently inferred pairwise TMRCA results from the TGP and SGDP to obtain a combined age estimate (*N*~Combined~). The number of haplotype pairs at which shared haplotype segments and TMRCA were inferred is shown for the two data sources; numbers are shown as the sum of concordant and discordant pairs analyzed per chromosome. See [S3 Text](#pbio.3000586.s016){ref-type="supplementary-material"} for details about the analysis of TGP and SGDP sample data. Full result data sets for each variant, including the results of each pairwise analysis and age estimates obtained under each clock model (mutation, recombination, and joint clock; see [S1 Text](#pbio.3000586.s014){ref-type="supplementary-material"}), are publicly available online at <https://human.genome.dating/>. SGDP, Simons Genome Diversity Project; TGP, 1000 Genomes Project; TMRCA, time to the most recent common ancestor.

(PDF)

###### 

Click here for additional data file.

###### Age and frequency of variants within population groups in TGP data.

We estimated allele age for variants identified in the TGP to characterize the age distribution of genetic variation across the human genome. Allele age was estimated under the joint clock model. Of the 43,232,520 variants dated in the TGP (chromosomes 1--22), we retained only those at quality score *QS* \> 0.5 (see [S1 Text](#pbio.3000586.s014){ref-type="supplementary-material"}) and at which the ancestral allele is known and mapped to the reference allele (see [S3 Text](#pbio.3000586.s016){ref-type="supplementary-material"}), which retained 34,388,511 variants. The table shows the number of variants (*N*) and the median of allele age estimates (*Q*~50~), as well as the 25th (*Q*~25~) and 75th (*Q*~75~) percentiles, per continental population group and stratified by allele frequency within that group. This is shown for (A) variants at nonzero frequencies within a given ancestry group, (B) geographically restricted variants that segregate only within a given group, and (C) strictly cosmopolitan variants that are shared among individuals from every continental group. AFR, African; AMR, American; EAS, East Asian; EUR, European; SAS, South Asian; TGP, 1000 Genomes Project.

(PDF)

###### 

Click here for additional data file.

###### Ancestry of individual HG00733.

The change in coalescence rate (intensity) over time for the two haploid genomes (chromosome 5) of target individual HG00733 (Puerto Rican in the American ancestry group) with all other genomes available through the TGP as comparator individuals; 5,070 haploid genomes in total, including related individuals that had been removed in the final release Phase 3 panel. Computations of the CCF and coalescent intensities are based on 2.3 million variants dated (joint clock model) on chromosome 5 from the TGP, retained after excluding variants of low estimation quality and inconsistent ancestral allele information. The movie shows the intensity scaled by the maximum over the TGP sample (top two panels), in which chromosomes are distinguished by maternal and paternal modes of inheritance (determined from coalescent intensity inferred with both parental genomes). The scaling factor (maximum of coalescent intensity across the sample) is shown separately (bottom left). An estimate of the effective population size (*N*~*e*~ equivalent; bottom right) is obtained from the scaling factor and the number of generations within a given time interval (epoch). The two lines show the *N*~*e*~ equivalent inferred for the maternally and paternally inherited chromosomes of the target individual. Epochs are shown on a sliding window, moving back in time, with epoch size as indicated (bottom). The full result data set for HG00733 is available online at <https://human.genome.dating/ancestry/HG00733>. CCF, cumulative coalescent function; TGP, 1000 Genomes Project.

(TXT)

###### 

Click here for additional data file.

###### Ancestry shared back in time for all individuals from the TGP.

The TGP sample consists of 2,535 individuals from 26 population groups, including related individuals that had been removed in the final release Phase 3 panel. We first computed the CCF for each of the 5,070 haploid genomes in turn with every other genome, separately for chromosomes 1--22. This was based on age estimates of 34.4 million variants dated using TGP data (joint clock model), retained after excluding variants of low estimation quality and inconsistent ancestral allele information; CCFs were then aggregated per diploid individual and across chromosomes. We then calculated the CIF from the aggregated CCF of each pair of individuals. Ancestral relationships are shown in a matrix (left), where colors indicate the coalescent intensity between each pair of individuals, scaled per target individual (rows) by the maximum over the sample per time interval (epoch). Labels indicate the continental population as defined in the TGP, which can be further subdivided into smaller population groups (see legend at end of movie). The movie shows ancestry backwards in time, where coalescent intensity is calculated in a sliding window with epoch size as indicated (top right). An estimate of the effective population size (*N*~*e*~ equivalent) is obtained per target individual from the maximum coalescent intensity across the sample and the time covered by a given epoch (bottom right); colors indicate an individual\'s ancestry group. Full result data sets for each individual are available online at <https://human.genome.dating/ancestry/index#TGP>. CCF, cumulative coalescent function; CIF, coalescent intensity function; TGP, 1000 Genomes Project.

(TXT)

###### 

Click here for additional data file.

###### Ancestry shared back in time for all individuals from the SGDP.

The SGDP sample consists of 278 individuals from 130 populations in the publicly available SGDP sample. We estimated the CIF from the aggregated CCF for each pair of individuals. CCFs were inferred separately per chromosome between each of the 556 haploid genomes as target in turn with all others as comparator genomes, based on 11.7 million variants dated under the joint clock model in the SGDP (chromosomes 1--22) and retained after excluding variants of low estimation quality and inconsistent ancestral allele information. These were then aggregated per diploid individual across chromosomes. As for [S2 Movie](#pbio.3000586.s012){ref-type="supplementary-material"}, ancestral relationships are shown in a matrix (left), moving back in time, in which colors show the scaled coalescent intensity per epoch (as indicated on the timeline; top right). Individuals are labeled according to their population group as defined in the SGDP sample (see legend at end of movie). Full result data sets for each individual are available online at <https://human.genome.dating/ancestry/index#SGDP>. CCF, cumulative coalescent function; CIF, coalescent intensity function; SGDP, Simons Genome Diversity Project.

(TXT)
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Click here for additional data file.

###### Genealogical Estimation of Variant Age (GEVA).

(PDF)

###### 

Click here for additional data file.

###### Analysis of data error and application in simulations.

(PDF)

###### 

Click here for additional data file.

###### Estimation of variant age in publicly available data sets.

(PDF)

###### 

Click here for additional data file.

###### Shared ancestry inference.

(PDF)

###### 

Click here for additional data file.

###### Inference of shared ancestry in simulated sample data.

(PDF)

###### 

Click here for additional data file.

###### Inference of shared ancestry between individuals and population groups in publicly available data sets.

(PDF)

###### 

Click here for additional data file.

We thank members of the McVean group for comments and discussion. We thank Robert Esnouf (Oxford Big Data Institute) for computational support. Computation used the Oxford Biomedical Research Computing (BMRC) facility, a joint development between the Wellcome Centre for Human Genetics and the Big Data Institute supported by Health Data Research UK and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the National Health Service (NHS), the NIHR, or the Department of Health.

AUC

:   area under the curve

BMRC

:   Biomedical Research Computing

CCF

:   cumulative coalescent function

CIF

:   coalescent intensity function

EDAR

:   Ectodysplasin A Receptor gene

ETPI

:   equal-tailed probability interval

GEVA

:   Genealogical Estimation of Variant Age

HLA

:   Human Leukocyte Antigene

HMM

:   hidden Markov model

IBD

:   identity by descent

IPG

:   Illumina Platinum Genomes Project

LCT

:   Lactase gene

LOESS

:   locally estimated scatterplot smoothing

LP

:   lactase persistence

MCM6

:   Minichromosome Maintenance Complex Component 6 gene

MRCA

:   most recent common ancestor

NHS

:   National Health Service

NIHR

:   National Institute for Health Research

PCA

:   principal component analysis

PolyPhen-2

:   Polymorphism Phenotyping v2 software

PRDM9

:   PR domain zinc finger protein 9

PSMC

:   pairwise sequentially Markovian coalescent

RMSLE

:   root mean-square log~10~ error

SGDP

:   Simons Genome Diversity Project

SIFT

:   Sorting Intolerant From Tolerant software

SNP

:   single-nucleotide polymorphism

TGP

:   1000 Genomes Project

TMRCA

:   time to the most recent common ancestor

ZEB1

:   Zinc finger E-box--binding homeobox 1 gene
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23 Jul 2019

Dear Dr Albers,

Thank you for submitting your manuscript entitled \"Dating genomic variants and shared ancestry in population-scale sequencing data\" for consideration as a Methods and Resources paper by PLOS Biology.

Your manuscript has now been evaluated by the PLOS Biology editorial staff, as well as by an academic editor with relevant expertise, and I\'m writing to let you know that we would like to send your submission out for external peer review.

However, before we can send your manuscript to reviewers, we need you to complete your submission by providing the metadata that is required for full assessment. To this end, please login to Editorial Manager where you will find the paper in the \'Submissions Needing Revisions\' folder on your homepage. Please click \'Revise Submission\' from the Action Links and complete all additional questions in the submission questionnaire.

\*\*Important\*\*: Please also see below for further information regarding completing the MDAR reporting checklist. The checklist can be accessed here: <https://plos.io/MDARChecklist>

Please re-submit your manuscript and the checklist, within two working days, i.e. by Jul 25 2019 11:59PM.

Login to Editorial Manager here: <https://www.editorialmanager.com/pbiology>

During resubmission, you will be invited to opt-in to posting your pre-review manuscript as a bioRxiv preprint. Visit <http://journals.plos.org/plosbiology/s/preprints> for full details. If you consent to posting your current manuscript as a preprint, please upload a single Preprint PDF when you re-submit.

Once your full submission is complete, your paper will undergo a series of checks in preparation for peer review. Once your manuscript has passed all checks it will be sent out for review.

Feel free to email us at <plosbiology@plos.org> if you have any queries relating to your submission.

Kind regards,

Roli Roberts

Roland G Roberts, PhD,

Senior Editor

PLOS Biology

==================

INFORMATION REGARDING THE REPORTING CHECKLIST:

PLOS Biology is pleased to support the \"minimum reporting standards in the life sciences\" initiative (<https://osf.io/preprints/metaarxiv/9sm4x/>). This effort brings together a number of leading journals and reproducibility experts to develop minimum expectations for reporting information about Materials (including data and code), Design, Analysis and Reporting (MDAR) in published papers. We believe broad alignment on these standards will be to the benefit of authors, reviewers, journals and the wider research community and will help drive better practise in publishing reproducible research.

We are therefore participating in a community pilot involving a small number of life science journals to test the MDAR checklist. The checklist is intended to help authors, reviewers and editors adopt and implement the minimum reporting framework.

IMPORTANT: We have chosen your manuscript to participate in this trial. The relevant documents can be located here:

MDAR reporting checklist (to be filled in by you): <https://plos.io/MDARChecklist>

\*\*We strongly encourage you to complete the MDAR reporting checklist and return it to us with your full submission, as described above. We would also be very grateful if you could complete this author survey:

<https://forms.gle/seEgCrDtM6GLKFGQA>

Additional background information:

Interpreting the MDAR Framework: <https://plos.io/MDARFramework>

Please note that your completed checklist and survey will be shared with the minimum reporting standards working group. However, the working group will not be provided with access to the manuscript or any other confidential information including author identities, manuscript titles or abstracts. Feedback from this process will be used to consider next steps, which might include revisions to the content of the checklist. Data and materials from this initial trial will be publicly shared in September 2019. Data will only be provided in aggregate form and will not be parsed by individual article or by journal, so as to respect the confidentiality of responses.

Please treat the checklist and elaboration as confidential as public release is planned for September 2019.

We would be grateful for any feedback you may have.

10.1371/journal.pbio.3000586.r002

Decision Letter 1

Roberts

Roland G

Senior Editor

© 2020 Roland G Roberts

2020

Roland G Roberts

This is an open access article distributed under the terms of the

Creative Commons Attribution License

, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

12 Sep 2019

Dear Dr Albers,

Thank you very much for submitting your manuscript \"Dating genomic variants and shared ancestry in population-scale sequencing data\" for consideration as a Methods and Resources paper at PLOS Biology. Your manuscript has been evaluated by the PLOS Biology editors, an Academic Editor with relevant expertise, and by three independent reviewers.

You\'ll see that the reviewers are broadly positive about your study, but have a number of requests for clarifications, additional analyses and presentational improvements. The Academic Editor asked us to emphasise that s/he shares reviewer \#2\'s uneasiness about your reliance on a single modal estimate (which is how most people will use the database), and thinks that this could be quite misleading in downstream analysis, since it discards information on the range of plausible estimates; s/he requests that you at least include some explicit discussion of this issue.

In light of the reviews (below), we are pleased to offer you the opportunity to address the comments from the reviewers in a revised version that we anticipate should not take you very long. We will then assess your revised manuscript and your response to the reviewers\' comments and we may consult the reviewers again. IMPORTANT: Note that reviewer \#2\'s comments are available in the downloadable attachment.

Your revisions should address the specific points made by each reviewer. Please submit a file detailing your responses to the editorial requests and a point-by-point response to all of the reviewers\' comments that indicates the changes you have made to the manuscript. In addition to a clean copy of the manuscript, please upload a \'track-changes\' version of your manuscript that specifies the edits made. This should be uploaded as a \"Related\" file type. You should also cite any additional relevant literature that has been published since the original submission and mention any additional citations in your response.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

Before you revise your manuscript, please review the following PLOS policy and formatting requirements checklist PDF: <http://journals.plos.org/plosbiology/s/file?id=9411/plos-biology-formatting-checklist.pdf>. It is helpful if you format your revision according to our requirements - should your paper subsequently be accepted, this will save time at the acceptance stage.

Please note that as a condition of publication PLOS\' data policy (<http://journals.plos.org/plosbiology/s/data-availability>) requires that you make available all data used to draw the conclusions arrived at in your manuscript. If you have not already done so, you must include any data used in your manuscript either in appropriate repositories, within the body of the manuscript, or as supporting information (N.B. this includes any numerical values that were used to generate graphs, histograms etc.). For an example see here: <http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5>.

For manuscripts submitted on or after 1st July 2019, we require the original, uncropped and minimally adjusted images supporting all blot and gel results reported in an article\'s figures or Supporting Information files. We will require these files before a manuscript can be accepted so please prepare them now, if you have not already uploaded them. Please carefully read our guidelines for how to prepare and upload this data: <https://journals.plos.org/plosbiology/s/figures#loc-blot-and-gel-reporting-requirements>.

Upon resubmission, the editors assess your revision and assuming the editors and Academic Editor feel that the revised manuscript remains appropriate for the journal, we may send the manuscript for re-review. We aim to consult the same Academic Editor and reviewers for revised manuscripts but may consult others if needed.

We expect to receive your revised manuscript within one month. Please email us (<plosbiology@plos.org>) to discuss this if you have any questions or concerns, or would like to request an extension. At this stage, your manuscript remains formally under active consideration at our journal; please notify us by email if you do not wish to submit a revision and instead wish to pursue publication elsewhere, so that we may end consideration of the manuscript at PLOS Biology.

When you are ready to submit a revised version of your manuscript, please go to <https://www.editorialmanager.com/pbiology/> and log in as an Author. Click the link labelled \'Submissions Needing Revision\' where you will find your submission record.

Thank you again for your submission to our journal. We hope that our editorial process has been constructive thus far, and we welcome your feedback at any time. Please don\'t hesitate to contact us if you have any questions or comments.

Sincerely,

Roli Roberts

Roland G Roberts, PhD,

Senior Editor

PLOS Biology

\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*

REVIEWERS\' COMMENTS:

Reviewer \#1:

This paper describes a very useful and carefully built resource: an atlas of allele age estimates for the variants in a large database of publicly available genomes. The algorithm used to infer these allele ages is clearly described in the supplement and represents a cogent heuristic for tackling this difficult problem. GEVA has the potential to be a 1-stop shop for local ancestry inference and demographic inference, two important classes of methods that usually involve different assumptions and software.

I have no significant concerns about the technical soundness of this manuscript. I do think it could be cleaned up a bit to improve its "user-friendliness"---the supplement is a very rich source of information, but it is not very well organized or indexed. I think the presentation of supplementary figures before the supplement index is counterproductive, and would prefer the index to be on the first page of this file so readers can more easily refer back to it.

The discussion of the paper is very short, especially given the breadth of results being presented, and it could be usefully expanded to flesh out how GEVA fits into the existing landscape of similar methods. For example, GEVA does some of the same things as tsinfer, another method from the McVean group, including inferring local ancestry profiles. Can the authors recommend when one local ancestry method may be more appropriate than the other, and how they are likely to compare to methods like chromopainter, RFmix, etc? In addition, the paper includes many PSMC-like plots, but it isn't clear whether the authors would recommend their method as an alternative to users who may be interested in running PSMC on new genomes from humans or other organisms. A biorxiv preprint by Leo Speidel, Simon Myers, et al. also estimates allele ages, and it would be useful to say something about the differences between the methods in performance and applicability.

The GEVA source code is available, but may or may not be as user-friendly as the database of variant ages that the authors obtained from a fixed set of publicly available genomes. Are the authors planning to keep updating the database as more genomes are sequenced, or are readers encouraged to run the method on other datasets themselves? Is it recommended for use on data from organisms other than humans? Do the authors expect that inferring demography directly from their coalescence time density functions might be more or less accurate than inferring demography using PSMC or other methods that incorporate site frequency spectrum information?

Minor comments:

-A PLoS Genetics paper recently published by Alexander Platt, Jody Hey, et al. also estimates allele ages. This should probably be referenced.

-The supplement presents a nice empirically calibrated error model that is trained on the discrepancies between the Illumina Platinum Genomes and less accurate sequences generated from the same cell lines. The model appears to generate posterior probability estimates as to whether a given variant is an error or not. These error probabilities are likely to be useful in downstream applications of the variant allele age database. Are they searchable within the database? When a variant is queried, will it be flagged as probably an error if appropriate?

Reviewer \#2:

IMPORTANT! Please see attached PDF

Reviewer \#3:

\[identifies himself as Aylwyn Scally\]

Just some quick comments from me. I like this paper, found it very interesting, and look forward to seeing it published. No major issues to raise, but I do have a couple of observations regarding the emphasis of the text which I think the authors should consider addressing.

Firstly, it seems a bit odd that the first section of the paper, and indeed the first figure, places such emphasis on the comparison with using PSMC to estimate allele ages. This feels like inside baseball \-- interesting from the perspective of algorithm development but not so important for understanding how it works. Perhaps I am missing something, but there didn\'t seem to be anything particularly surprising; using PSMC the method performed similarly, as one would expect, barring discretisation, in terms of accuracy if not speed, and the take-away message is that the authors\' tailored approach was faster without adding bias or error. This is good but I think the simulation comparison alone without PSMC would be more meaningful for most readers, in terms of convincing the reader that the method does a good job at recovering allele age, which I think is the main task at this point in the paper. I\'d put the PSMC aspect in the supplement.

Secondly, and perhaps more importantly, I\'d like to see the paper give a bit more focus to the comparison with allele frequencies. A lot of people will approach this study and the resources presented as a more accurate way to incorporate allele age into their analyses than simply using allele frequency as a proxy. Figures 4A and S6 give some useful information, but I think the presentation and discussion is a bit limited. One thing to note, for example, is how contingent allele age is on population of ascertainment. For example the rarest alleles (\<1%) if ascertained in Africa are on average about twice the age of equivalent alleles ascertained in Europe or East Asia. More pertinently, are there any cases where using frequency as a proxy might be misleading or biased, relative to using the ages estimated here? My overall impression is that frequency is a pretty good proxy for age if ascertained straightforwardly in a single G1k population - but the mapping is nonlinear and does not transfer between populations.

There are also some interesting signals in figure S6. The text points out the striking signal of recent African admixture in America, but there is also an apparent sign of recent gene flow from Africa into Europe, manifesting as an excess of old but very rare alleles there. At least, that is how I read the plot in the fourth panel of the top row \-- do the authors concur? A consequence of this is presumably also seen in figure 4A, where European variants older than \~25000 years are apparently more likely to be in the rarest frequency bin than the next most common.

Aylwyn Scally

###### 

Submitted filename: GEVA_review (1).pdf

###### 

Click here for additional data file.

10.1371/journal.pbio.3000586.r003
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Click here for additional data file.
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21 Nov 2019

Dear Dr Albers,

Thank you for submitting your revised Methods and Resources entitled \"Dating genomic variants and shared ancestry in population-scale sequencing data\" for publication in PLOS Biology. I have now obtained advice from one of the original reviewers and have discussed their comments with the Academic Editor.

We\'re delighted to let you know that we\'re now editorially satisfied with your manuscript. However before we can formally accept your paper and consider it \"in press\", we also need to ensure that your article conforms to our guidelines. A member of our team will be in touch shortly with a set of requests. As we can\'t proceed until these requirements are met, your swift response will help prevent delays to publication. Please also make sure to address the Data Policy-related requests noted at the end of this email.

\*Copyediting\*

Upon acceptance of your article, your final files will be copyedited and typeset into the final PDF. While you will have an opportunity to review these files as proofs, PLOS will only permit corrections to spelling or significant scientific errors. Therefore, please take this final revision time to assess and make any remaining major changes to your manuscript.

NOTE: If Supporting Information files are included with your article, note that these are not copyedited and will be published as they are submitted. Please ensure that these files are legible and of high quality (at least 300 dpi) in an easily accessible file format. For this reason, please be aware that any references listed in an SI file will not be indexed. For more information, see our Supporting Information guidelines:

<https://journals.plos.org/plosbiology/s/supporting-information>

\*Published Peer Review History\*

Please note that you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. Please see here for more details:

<https://blogs.plos.org/plos/2019/05/plos-journals-now-open-for-published-peer-review/>

\*Early Version\*

Please note that an uncorrected proof of your manuscript will be published online ahead of the final version, unless you opted out when submitting your manuscript. If, for any reason, you do not want an earlier version of your manuscript published online, uncheck the box. Should you, your institution\'s press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us as soon as possible if you or your institution is planning to press release the article.

\*Submitting Your Revision\*

To submit your revision, please go to <https://www.editorialmanager.com/pbiology/> and log in as an Author. Click the link labelled \'Submissions Needing Revision\' to find your submission record. Your revised submission must include a cover letter, a Response to Reviewers file that provides a detailed response to the reviewers\' comments (if applicable), and a track-changes file indicating any changes that you have made to the manuscript.

Please do not hesitate to contact me should you have any questions.

Sincerely,

Roli Roberts

Roland G Roberts, PhD,

Senior Editor

PLOS Biology

\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--

DATA POLICY:

You may be aware of the PLOS Data Policy, which requires that all data be made available without restriction: <http://journals.plos.org/plosbiology/s/data-availability>. For more information, please also see this editorial: <http://dx.doi.org/10.1371/journal.pbio.1001797>

Note that we do not require all raw data. Rather, we ask that all individual quantitative observations that underlie the data summarized in the figures and results of your paper be made available in one of the following forms:

1\) Supplementary files (e.g., excel). Please ensure that all data files are uploaded as \'Supporting Information\' and are invariably referred to (in the manuscript, figure legends, and the Description field when uploading your files) using the following format verbatim: S1 Data, S2 Data, etc. Multiple panels of a single or even several figures can be included as multiple sheets in one excel file that is saved using exactly the following convention: S1_Data.xlsx (using an underscore).

2\) Deposition in a publicly available repository. Please also provide the accession code or a reviewer link so that we may view your data before publication.

Regardless of the method selected, please ensure that you provide the individual numerical values that underlie the summary data displayed in the figure panels as they are essential for readers to assess your analysis and to reproduce it. I note that most of the data presented are probably available in <https://human.genome.dating> - if so, please could you cite this in all relevant main and Supp Fig legends (I know you already do in some). However, there are several Figures where I\'m uncertain whether the data come directly from <https://human.genome.dating> (e.g. Fig 2); if not, we will need you to provide them in another form (see above) and cite the location accordingly.

NOTE: the numerical data provided should include all replicates AND the way in which the plotted mean and errors were derived (it should not present only the mean/average values).

Please also ensure that figure legends in your manuscript include information on where the underlying data can be found, and ensure your supplemental data file/s has a legend.

Please ensure that your Data Statement in the submission system accurately describes where your data can be found.

\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--

REVIEWERS\' COMMENTS:

Reviewer \#2:

\[identifies himself as Yuval Simons\]

I thank the authors for taking the time to address all the issues raised in the previous round of reviews in such meticulous detail.

I think this elegant and exciting work is ready for publication.

\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--

10.1371/journal.pbio.3000586.r005
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2 Jan 2020

Dear Dr Albers,

On behalf of my colleagues and the Academic Editor, Nick H. Barton, I am pleased to inform you that we will be delighted to publish your Methods and Resources in PLOS Biology.

The files will now enter our production system. You will receive a copyedited version of the manuscript, along with your figures for a final review. You will be given two business days to review and approve the copyedit. Then, within a week, you will receive a PDF proof of your typeset article. You will have two days to review the PDF and make any final corrections. If there is a chance that you\'ll be unavailable during the copy editing/proof review period, please provide us with contact details of one of the other authors whom you nominate to handle these stages on your behalf. This will ensure that any requested corrections reach the production department in time for publication.

Early Version

The version of your manuscript submitted at the copyedit stage will be posted online ahead of the final proof version, unless you have already opted out of the process. The date of the early version will be your article\'s publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

PRESS

We frequently collaborate with press offices. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximise its impact. If the press office is planning to promote your findings, we would be grateful if they could coordinate with <biologypress@plos.org>. If you have not yet opted out of the early version process, we ask that you notify us immediately of any press plans so that we may do so on your behalf.

We also ask that you take this opportunity to read our Embargo Policy regarding the discussion, promotion and media coverage of work that is yet to be published by PLOS. As your manuscript is not yet published, it is bound by the conditions of our Embargo Policy. Please be aware that this policy is in place both to ensure that any press coverage of your article is fully substantiated and to provide a direct link between such coverage and the published work. For full details of our Embargo Policy, please visit <http://www.plos.org/about/media-inquiries/embargo-policy/>.

Thank you again for submitting your manuscript to PLOS Biology and for your support of Open Access publishing. Please do not hesitate to contact me if I can provide any assistance during the production process.

Kind regards,

Hannah Harwood

Publication Assistant,

PLOS Biology

on behalf of

Roland Roberts,

Senior Editor

PLOS Biology

[^1]: I have read the journal\'s policy and the authors of this manuscript have the following competing interests: GM is a shareholder in and non-executive director of Genomics PLC, and is a partner in Peptide Groove LLP. PKA is a shareholder in and a director of BioMe Oxford Ltd.
